Absci
Designs antibody drug candidates with generative AI and validates them in its own wet lab.
$8.75
After-hours close+0.03 (+0.34%)
At close$8.72(−7.43%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 90.11%152.65M sharesInsiders 6.13%10.38M sharesOther 3.76%6.37M shares
Shares outstanding 169.40M · Float 146.89M · 86.7% free float
Institutions13F, as of Jun 30, 2026
206 holders · 152.65M shares · 53 new positions · 129 increased · 48 reduced · 17 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 25.41M | 15.00% | +2.86M | Aug 13, 2026 |
| Ark Investment Management LLC | 12.93M | 7.63% | −800.9K | Aug 14, 2026 |
| BlackRock, Inc. | 12.18M | 7.19% | +920.1K | Aug 7, 2026 |
| State Street Corp | 8.10M | 4.78% | +772.5K | Aug 7, 2026 |
| Ameriprise Financial Inc | 6.99M | 4.13% | +3.81M | Aug 14, 2026 |
| Redmile Group, LLC | 6.74M | 3.98% | −1.51M | Aug 14, 2026 |
| Vanguard Capital Management LLC | 6.12M | 3.61% | +236.0K | Aug 13, 2026 |
| Advanced Micro Devices Inc | 5.71M | 3.37% | 0 | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 14.40% | 18.39M | 13G | May 12, 2025 ↗ |
| ARK Investment Management LLC | 8.60% | 10.96M | 13G | May 14, 2025 ↗ |
| Sean McClain | 7.20% | 11.00M | 13G | Nov 13, 2025 ↗ |
| BlackRock, Inc. | 6.50% | 8.32M | 13G | Jul 16, 2025 ↗ |
| Redmile Group, LLCincl. Jeremy C. Green | 5.40% | 8.25M | 13D | Mar 26, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Sean McClain | director, officer: Chief Executive Officer | 8.66M | 5.11% | Jun 26, 2026 |
| Zachariah Jonasson | officer: CFO / CBO | 491.5K | 0.29% | Jun 1, 2026 |
| Andreas Busch | officer: Chief Innovation Officer | 421.4K | 0.25% | Mar 16, 2026 |
| Menelas N. Pangalos | director | 242.4K | 0.14% | Jun 8, 2026 |
| Todd Bedrick | officer: SVP, CAO | 216.9K | 0.13% | Mar 4, 2026 |
| Shelby J. Walker | officer: Chief Legal Officer | 139.8K | 0.08% | Mar 4, 2026 |
| Frans van Houten | director | 73.4K | 0.04% | Jun 8, 2026 |
| Karen K. Mcginnis | director | 48.4K | 0.03% | Jun 11, 2026 |
| Daniel A. Rabinovitsj | director | 33.4K | 0.02% | Jun 8, 2026 |
| Joseph Sirosh | director | 33.4K | 0.02% | Jun 8, 2026 |
1 ten-percent owner holds 11.28M shares by Form 4, outside the officers-and-directors figure above · 8 people have not refiled in the last 18 months (18.10M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 30, 2026 | Mary T. Szeladirector | Purchase | 12,900 | $11.54 | 21,300 |
| May 13, 2026 | Menelas N. Pangalosdirector | Purchase | 37,453 | $5.36 | 232,308 |
| Mar 12, 2026 | Andreas Buschofficer: Chief Innovation Officer | Purchase | 100,000 | $2.29 | 421,446 |
| Feb 27, 2026 | Menelas N. Pangalosdirector | Purchase | 75,095 | $2.74 | 189,055 |
| Feb 2, 2026 | Zachariah Jonassonofficer: CFO / CBO | Sale | 17,496 | $2.99 | 383,538 |
| Feb 2, 2026 | Sean McClaindirector, officer: Chief Executive Officer | Sale | 26,761 | $2.99 | 8,334,567 |
| Dec 5, 2025 | Frans van Houtendirector | Purchase | 40,000 | $3.72 | 63,320 |
| Sep 22, 2025 | Todd Bedrickofficer: SVP, CAO | Purchase | 10,000 | $2.70 | 180,428 |
| Sep 22, 2025 | Menelas N. Pangalosdirector | Purchase | 95,785 | $2.66 | 113,960 |
CongressHouse and Senate disclosures
Not reported.